PortfoliosLab logoPortfoliosLab logo
ISIN
US1570851014
CUSIP
157085101
IPO Date
Jan 30, 1997

Highlights

Market Cap
$504.77M
Enterprise Value
$597.38M
EPS (TTM)
-$0.05
Total Revenue (TTM)
$216.56M
Gross Profit (TTM)
$114.76M
EBITDA (TTM)
-$2.69M
Year Range
$1.15 - $3.15
Target Price
$4.00
ROA (TTM)
-4.28%
ROE (TTM)
-13.99%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

CERS Performance Chart

Cerus Corporation (CERS) is up 26.2% since the beginning of the year. At $3 per share, CERS is trading 17.5% below its 52-week high of $3. Investors who bought $1,000 worth of CERS shares 5 years ago would now be looking at an investment worth $456.


Loading charts...

S&P 500 Index

Returns By Period

Cerus Corporation (CERS) has returned 26.21% so far this year and 94.03% over the past 12 months. Over the last ten years, CERS has returned -8.07% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.


Cerus Corporation

1D
-3.70%
1M
-4.06%
YTD
26.21%
6M
22.64%
1Y
94.03%
3Y*
2.70%
5Y*
-14.53%
10Y*
-8.07%

Benchmark (S&P 500 Index)

1D
-0.37%
1M
-0.01%
YTD
9.16%
6M
8.64%
1Y
25.22%
3Y*
19.78%
5Y*
11.99%
10Y*
13.88%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CERS Monthly Returns History

Based on dividend-adjusted daily data since Jan 31, 1997, CERS's average daily return is +0.07%, while the average monthly return is +1.31%. At this rate, an investment would double in approximately 4.4 years.

Historically, 49% of months were positive and 51% were negative. The best month was Apr 2009 with a return of +72.1%, while the worst month was Jan 2003 at -61.1%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 6 months.

On a daily basis, CERS closed higher 46% of trading days. The best single day was Aug 19, 2009 with a return of +60.9%, while the worst single day was Jan 31, 2003 at -41.6%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202613.11%9.87%-28.91%11.54%49.75%-14.47%26.21%
202521.43%-11.76%-15.76%-5.04%-3.79%11.02%-9.22%2.34%21.37%-7.55%19.73%17.05%33.77%
2024-16.20%20.44%-13.30%-11.64%7.19%-1.68%28.41%0.00%-23.01%-9.77%17.83%-16.76%-28.70%
2023-13.97%-8.92%3.85%-22.22%-7.36%14.95%24.80%-38.44%-14.29%-13.58%15.00%34.16%-40.82%
2022-21.29%9.51%-6.47%-15.85%7.14%6.87%2.08%-23.89%-12.41%1.67%9.29%-8.75%-46.40%
2021-4.77%-6.83%-2.12%1.50%-5.08%2.07%-14.72%27.98%-5.58%8.37%4.39%-1.16%-1.59%

Benchmark Metrics

Cerus Corporation has an annualized alpha of 7.84%, beta of 1.08, and R2 of 0.09 versus S&P 500 Index. Calculated based on daily prices since January 31, 1997.

  • This stock participated in 154.31% of S&P 500 Index downside but only 107.52% of its upside - more exposed to losses than it benefited from rallies.
  • R2 of 0.09 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
7.84%
Beta
1.08
0.09
Upside Capture
107.52%
Downside Capture
154.31%

Return for Risk

Risk / Return Rank

CERS ranks 78 for risk / return — better than 78% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.


CERS Risk / Return Rank: 7878
Overall Rank
CERS Sharpe Ratio Rank: 7878
Sharpe Ratio Rank
CERS Sortino Ratio Rank: 7979
Sortino Ratio Rank
CERS Omega Ratio Rank: 7575
Omega Ratio Rank
CERS Calmar Ratio Rank: 8080
Calmar Ratio Rank
CERS Martin Ratio Rank: 7979
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Cerus Corporation (CERS) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CERSBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-0.77

Sortino ratioReturn per unit of downside risk

-0.58

Omega ratioGain probability vs. loss probability

1.26

1.37

-0.11

Calmar ratioReturn relative to maximum drawdown

2.47

2.78

-0.32

Martin ratioReturn relative to average drawdown

5.71

12.44

-6.73

Dividends

Dividend History


Cerus Corporation doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Cerus Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Cerus Corporation was 99.28%, occurring on Dec 16, 2008. The portfolio has not yet recovered.

The current Cerus Corporation drawdown is 96.77%.


Related event

Drawdown

Fall

Recovery

Underwater

Financial crisis2007–2009
-99.28%Dec 2008
7y 11mo
25y 6moDec 2000 - now
Dot-com crash2000–2002
-58.57%Apr 2000
1mo 10d8mo 8d
9mo 18dMar 2000 - Dec 2000
1998 bear market1998
-51.52%Apr 1998
4mo 15d8mo 27d
1y 1moDec 1997 - Jan 1999
1999 bear market1999
-50.59%Apr 1999
2mo 29d8mo 21d
11mo 20dJan 1999 - Jan 2000
1997 bear market1997
-36.73%Feb 1997
16d1mo 20d
2mo 6dFeb 1997 - Apr 1997

Drawdown Indicators


CERSBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-99.28%

-56.78%

-42.50%

Max Drawdown (1Y)

Largest decline over 1 year

-38.32%

-9.10%

-29.22%

Max Drawdown (3Y)

Largest decline over 3 years

-62.21%

-18.90%

-43.31%

Max Drawdown (5Y)

Largest decline over 5 years

-85.37%

-25.43%

-59.94%

Max Drawdown (10Y)

Largest decline over 10 years

-86.45%

-33.92%

-52.53%

Current Drawdown

Current decline from peak

-96.77%

-1.80%

-94.97%

Average Drawdown

Average peak-to-trough decline

-81.40%

-10.71%

-70.69%

Ulcer Index

Depth and duration of drawdowns from previous peaks

16.53%

2.03%

+14.50%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Cerus Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Cerus Corporation is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for CERS relative to other companies in the Biotechnology industry. Currently, CERS has a P/S ratio of 2.3. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for CERS in comparison with other companies in the Biotechnology industry. Currently, CERS has a P/B value of 7.4. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with CERS

Add Cerus Corporation to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with CERS